How Allergan Beat Estimates in What's Likely Its Last Quarterly Update
Allergan (NYSE: AGN) entered 2020 with a lot of momentum. AbbVie's (NYSE: ABBV) announcement of its plans to acquire Allergan gave the stock a big boost. That news was so great that investors didn't care that Allergan delivered less-than-exciting third-quarter results in November.
But there were some things to energize investors in Allergan's 2019 fourth-quarter results, announced before the market opened on Monday. Here are the highlights from the company's Q4 update.
Image source: Getty Images.
Source Fool.com
